Fiche publication


Date publication

août 2026

Journal

Cell reports

Auteurs

Membres identifiés du Cancéropôle Est :
Pr RICCI Roméo


Tous les auteurs :
Magalhaes MS, Malengier-Devlies B, Seuzaret G, Ahlback A, Becker S, Patatsos K, Drakoulis G, Karjalainen J, Ruedl C, Voehringer D, Bain CC, Emmerson E, Schonfeldova B, Zec K, Udalova I, Simakou T, MacDonald L, Kurowska-Stolarska M, Miotla-Zarebska J, Vincent T, Ricci R, Erbs E, Barrington J, McColl BW, Neag G, Mahony C, Croft AP, Boon L, Vermeren M, Bajénoff M, Ben Brahim O, Uderhardt S, Gallerand A, Ivanov S, Gentek R

Résumé

The synovial lining maintains joint integrity, produces lubricating fluid, and forms a sterile barrier disrupted in inflammatory joint disease. It consists of specialized fibroblasts and macrophages, but its developmental timing and mechanisms are not well understood. We used genetic mouse models, imaging, and single-cell transcriptomic profiling to delineate this process. We found that the lining is immature in fetal human and newborn mouse joints. In mice, fibroblasts provide full coverage at birth, whereas macrophages are scarce. The macrophage lining layer gradually forms during the first weeks of life in a colony-stimulating factor 1 (CSF1)-dependent process, largely monocyte-independent, involving fetal-derived Cx3cr1 macrophages and Aqp1 intermediates. Both lining macrophages and fibroblasts undergo substantial transcriptional changes postnatally, acquiring their specific identity, upregulating key genes such as Prg4 (fibroblasts) and Vsig4 (macrophages), and establishing active signaling units. Early postnatal life is therefore a critical window for synovial lining maturation with implications for joint health and disease.

Mots clés

CP: developmental biology, CP: immunology, Macrophages, development, fibroblasts, lining, synovial joints

Référence

Cell Rep. 2026 08 14;45(8):117698